Leerink Partnrs Has Bullish Estimate for THC Q2 Earnings

Tenet Healthcare Co. (NYSE:THC - Free Report) - Leerink Partnrs lifted their Q2 2025 EPS estimates for shares of Tenet Healthcare in a research note issued on Tuesday, April 29th. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings of $2.90 per share for the quarter, up from their prior estimate of $2.62. The consensus estimate for Tenet Healthcare's current full-year earnings is $12.24 per share. Leerink Partnrs also issued estimates for Tenet Healthcare's FY2025 earnings at $12.25 EPS and Q2 2026 earnings at $3.51 EPS.

A number of other research firms have also recently commented on THC. StockNews.com raised shares of Tenet Healthcare from a "hold" rating to a "buy" rating in a research report on Thursday, May 1st. Guggenheim assumed coverage on shares of Tenet Healthcare in a report on Wednesday, April 9th. They set a "buy" rating and a $165.00 price objective on the stock. UBS Group raised their target price on Tenet Healthcare from $217.00 to $230.00 and gave the company a "buy" rating in a research report on Wednesday, April 30th. Robert W. Baird reaffirmed a "neutral" rating and set a $137.00 price target (down previously from $153.00) on shares of Tenet Healthcare in a research report on Tuesday, April 15th. Finally, The Goldman Sachs Group lifted their target price on shares of Tenet Healthcare from $134.00 to $154.00 and gave the company a "neutral" rating in a report on Monday. Four analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $173.69.

Tenet Healthcare Trading Up 0.2 %

Shares of THC traded up $0.24 during trading hours on Friday, reaching $151.72. 390,410 shares of the company traded hands, compared to its average volume of 1,541,463. The stock's fifty day moving average price is $127.86 and its 200 day moving average price is $136.11. The company has a current ratio of 1.78, a quick ratio of 1.70 and a debt-to-equity ratio of 2.25. The firm has a market cap of $14.09 billion, a price-to-earnings ratio of 4.71, a PEG ratio of 1.02 and a beta of 1.63. Tenet Healthcare has a 12-month low of $109.82 and a 12-month high of $171.20.

Tenet Healthcare (NYSE:THC - Get Free Report) last released its earnings results on Tuesday, April 29th. The company reported $4.36 earnings per share for the quarter, beating the consensus estimate of $3.11 by $1.25. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. The company had revenue of $5.22 billion for the quarter, compared to the consensus estimate of $5.15 billion. During the same period in the previous year, the business earned $3.22 earnings per share. Tenet Healthcare's quarterly revenue was down 2.5% compared to the same quarter last year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in the business. Norges Bank acquired a new position in shares of Tenet Healthcare in the 4th quarter worth $190,819,000. Wealthfront Advisers LLC bought a new position in Tenet Healthcare during the fourth quarter valued at approximately $69,059,000. Raymond James Financial Inc. acquired a new position in Tenet Healthcare during the fourth quarter worth $49,001,000. Renaissance Technologies LLC raised its position in shares of Tenet Healthcare by 579.2% in the fourth quarter. Renaissance Technologies LLC now owns 438,563 shares of the company's stock valued at $55,360,000 after purchasing an additional 373,988 shares during the period. Finally, Bridgewater Associates LP boosted its holdings in Tenet Healthcare by 225.4% during the fourth quarter. Bridgewater Associates LP now owns 407,194 shares of the company's stock valued at $51,400,000 after acquiring an additional 282,071 shares during the period. Institutional investors and hedge funds own 95.44% of the company's stock.

Insider Activity at Tenet Healthcare

In related news, Director J Robert Kerrey sold 9,525 shares of the firm's stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total transaction of $1,194,720.75. Following the completion of the sale, the director now directly owns 27,378 shares of the company's stock, valued at approximately $3,434,022.54. This trade represents a 25.81 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.81% of the company's stock.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.